Simultaneous Spectrophotometric Determination of Levodopa and Benserazide in a Pharmaceutical

ABSTRACT

A method based on a partial least-squares calibration (PLS) for the simultaneous spectrophotometric determination of levodopa (I) and benserazide (II) in a commercially available pharmaceutical preparation is proposed. The calibration procedure was developped by using laboratory made mixtures of I and II, and optimized by selecting the most suitable wavelength range and spectral mode. The relative standard error of prediction (RSEP %) was 0.5% and 0.9% with a limiting reproducibility (R) of 4 10^?6 M and 1.5 10^?6 M for levodopa and benserazide, respectively The proposed method is straightforward, expeditious and precise. Its results are consistent with those provided by HPLC for the two analytes.     

Capillary electrophoresis with electrochemiluminescence detection for the simultaneous determination of cisatracurium besylate and its degradation products in pharmaceutical preparations

Capillary electrophoresis with electrochemiluminescence detection for the simultaneous analysis of cisatracurium besylate and its degradation products (laudanosine, quaternary monoacrylate) in pharmaceutical preparation was developed and fully validated. The significant parameters that influence capillary electrophoresis separation and electrochemiluminescence detection were optimized. The total analysis time of the analytes was 15 min. The linearities of the method were 0.1～40.0 μg/mL for cisatracurium besylate and 0.04～8.00 μg/mL for laudanosine, with correlation coefficients (r) of 0.999 and 0.998, respectively. The detection limits (S/N = 3) were 83.0 ng/mL for cisatracurium besylate and 32.0 ng/mL for laudanosine. The intraday relative standard deviations of the analytes were <3.0%, and the interday relative standard deviations were <8.0%. The developed method was cost‐effective, sensitive, fast, and resource‐saving, which was suitable for the ingredient analysis in pharmaceutical preparation.     

Simultaneous kinetic spectrophotometric determination of spironolactone and canrenone in urine using partial least-squares regression

A method is proposed for the simultaneous determination of spironolactone and canrenone in urine based on the different rates at which they react with sulphuric acid to yield a trienone. Kinetic spectrophotometric data are processed by partial least-squares (PLS) regression. The optimum sulphuric acid concentration and temperature are determined from response surfaces, using PLS methodology to relate both variables to the relative square error of prediction (RSEP, the parameter to be minimized). The relative errors made in the quantitation of each diuretic by the proposed method are less than 5% and the overall error, as RSEP, ranges from 1.06 and 1.44%.     

Simultaneous separation and rapid determination of spironolactone and its metabolite canrenone in different pharmaceutical formulations and urinary matrices by capillary zone electrophoresis

The aim of this study was to develop a novel, sensitive, precise, simple, and rapid capillary zone electrophoresis method for the quality control of spironolactone in three different formulation types and a rapid simultaneous determination of the content of spironolactone and canrenone in urine samples using fluocinonide as an internal standard. After optimization of separation conditions, the electrolyte solution was the pH 5.5, 20 mM phosphate buffer containing 4.5 g/L sulfated‐β‐cyclodextrin, 15 kV of electric filed across the capillary applied at 25°C. A diode array detector was used, and the detection wavelength was 260 nm. Under optimum conditions, good linearity was achieved with correlation coefficients from 0.9976 to 0.9997. Detection limits were 0.56 and 0.20 μg/mL, and the quantitation limits were 1.87 and 0.67 μg/mL, respectively. Excellent accuracy and precision were obtained. Recoveries of the analytes varied from 100.8 to 103.1%. The results indicated that baseline separation of analytes was obtained and this method was suitable for quantitative determination of spironolactone in pharmaceutical preparations and rapid simultaneous determination of the content of spironolactone and its major metabolite canrenone in urine samples.     

A multivariate approach for the simultaneous determination of losartan potassium and hydrochlorothiazide in a combined pharmaceutical tablet formulation

A convenient new method for the simultaneous determination of losartan potassium and hydrochlorothiazide, with minimum sample pretreatment, is described. The procedure, based on the multivariate analysis of spectral data in the 220−274 nm region by the partial least squares algorithm, is linear in the concentration range 1.06−5.70 mg L⁻¹ for hydrochlorothiazide and 4.0−22.2 mg L⁻¹ for losartan. It is simple, rapid and robust, allowing accurate and precise results, with drug recovery rates of 99.3 and 100.4% and relative standard deviations of 1.7 and 1.0% obtained for hydrochlorothiazide and losartan, respectively. The method was applied to the simultaneous determination of both analytes in tablets, and it provided good results which were in statistical agreement with those provided by independent HPLC analyses of the samples. The method has also been successfully applied for the construction of drug dissolution profiles of a commercial pharmaceutical preparation containing both analytes. Figure A UV-PLS method for the simultaneous determination of losartan potassium and hydrochlorothiazide in pharmaceutical tablet formulations has been developed and validated     

Simultaneous Determination of Atenolol and Chlorthalidone in Pharmaceutical Preparations by Capillary-Zone Electrophoresis

Abstract

A capillary zone electrophoresis (CZE) method for the simultaneous determination of the β-blocker drugs atenolol and chlorthalidone in pharmaceutical formulations has been developed. The CZE separation was performed under the following conditions: capillary temperature, 25°C; applied voltage, 25 kV; 20 mM H₃PO₄–NaOH running buffer (pH 9.0); and detection wavelength, 198 nm. Phenobarbital was used as internal standard. The method was validated and showed not only good precision and accuracy but also good robustness. The method has been successfully applied to the simultaneous determination of both atenolol and chlorthalidone in pharmaceutical tablets.     

Simultaneous spectrophotometric determination of diuretics by using multivariate calibration methods

The wavelength range and number of factors used in partial least-squares (PLS) calibration for the resolution of the dihydralazine (DHZ)-hydrochlorothiazide (HCT) binary mixture and the dihydralazine-hydrochlorothiazide-reserpine ternary mixture were optimized in terms of the relative standard error (R.S.E.) and relative mean standard error (R.M.S.E.). Under the optimum conditions thus established, synthetic mixtures of the analytes can be resolved with errors and relative standard deviations (R.S.D) less than 4.5 and 1.0%, respectively. The ensuing method, which was validated by comparison with high performance liquid chromatography (HPLC), also gives good results with real samples (pharmaceutical preparations).     

Synchronized stability indicating RP-LC methods for determination of metolazone with losartan potassium or spironolactone in presence of their degradation products

Abstract

Two precise and selective stability-indicating RP-LC methods have been developed and validated for simultaneous determination of metolazone in its binary mixture with losartan potassium (method 1) and spironolactone (method 2) in the presence of their degradation products. For method 1, the chromatographic separation was achieved on Kromasil C₁₈ column, the mobile phase consisted of a mixture of 0.1% ortho-phosphoric acid in acetonitrile and 0.1% ortho-phosphoric acid in water (28:72, v/v) pumped at flow rate 2?mL/min and UV detection at 235?nm. Linearity was determined over the concentration range of 2–16µg/mL for metolazone and 40–320µg/mL for losartan potassium. For method 2, chromatographic separation of metolazone and spironolactone was achieved on a Symmetry C₈ column using a mobile phase that consisted of acetonitrile, methanol, and 0.1% ortho-phosphoric in water in gradient mode pumped at a flow rate 1.5?mL/min with programed wavelength detection. Linearity was determined over the concentration range of 2–16µg/mL for metolazone and 20–160µg/mL for spironolactone. The suggested methods were proved to be highly selective, precise and accurate for simultaneous determination of the cited drugs in their combined pharmaceutical dosage form in the presence of their degradation products. The proposed methods were validated in compliance with ICH guidelines.

1. Highlights

2. Synchronized determination of metolazone and co-formulated drugs in presence of their degradation products.

3. Act as a method for screening of metolazone and co-formulated drugs in quality control laboratories.

4. Validation of suggested methods according to ICH guidelines.

5. The pathway of degradation of metolazone under different stress conditions was proposed.

     

Simultaneous determination of atenolol,chlorthalidone and amiloride in pharmaceutical preparations by capillary zone electrophoresis with ultraviolet detection

Capillary zone electrophoresis methods for the simultaneous determination of the β‐blocker drugs, atenolol, chlorthalidone and amiloride, in pharmaceutical formulations have been developed. The influences of several factors (buffer pH, concentration, applied voltage, capillary temperature and injection time) were studied. Using phenobarbital as internal standard, the analytes were all separated in less than 4 min. The separation was carried out in normal polarity mode at 25°C, 25 kV and using hydrodynamic injection (10 s). The separation was effected in an uncoated fused‐silica capillary (75 μm i.d. × 52 cm) and a background electrolyte of 25 mm H₃PO₄ adjusted with 1 m NaOH solution (pH 9.0) and detection at 198 nm. The method was validated with respect to linearity, limit of detection and quantification, accuracy, precision and selectivity. Calibration curves were linear over the range 1–250 μg/mL for atenolol and chlorthalidone and from 2.5–250 μg/mL for amiloride. The relative standard deviations of intra‐ and inter‐day migration times and corrected peak areas were less than 6.0%. The method showed good precision and accuracy and was successfully applied to the simultaneous determination of atenolol, chlorthalidone and amiloride in various pharmaceutical tablets formulations. Copyright © 2010 John Wiley & Sons, Ltd.     

Simultaneous determination of N-butylscopolamine and oxazepam in pharmaceutical formulations by first-order digital derivative spectrophotometry

A simple method has been developed for the simultaneous determination of N-butylscopolamine bromide and oxazepam in pharmaceutical formulations using first-order digital derivative spectrophotometry. Acetonitrile was selected as the solvent in which both compounds showed well-defined bands. Both analytes showed good stability in this solvent when solutions of the analytes were exposed to light and temperatures between 20 degrees and 80 degrees C. The simultaneous determination of both drugs was performed by the zero-crossing method at 226.0 and 257.0 nm for N-butylscopolamine and oxazepam, respectively. The linear range of determination was found to be 2.5 x 10(-7) to 8.0 x 10(-5) mol/L for N-butylscopolamine and 7.1 x 10(-8) to 8.0 x 10(-5) mol/L for oxazepam. A very good level of repeatability (relative standard deviation) of 0.2% was observed for N-butylscopolamine and oxazepam. The ingredients commonly found in pharmaceutical formulations do not interfere. The proposed method was applied to the determination of these drugs in pharmaceutical formulations (capsules).     

Development of validated RP HPLC method with fluorescence detection for simultaneous quantification of sacubitril and valsartan from rat plasma

In the present work, a sensitive, accurate and precise RP HPLC method has been established for simultaneous determination of sacubitril and valsartan from rat plasma by using irbesartan as an internal standard. Separation of analytes were carried out on monolithic column using 10?mM phosphate buffer (pH 2.6), methanol and acetonitrile in a proportion of 50:25:25 (v/v). Analytes were monitored using fluorescence detector maintained at an excitation wavelength of 249?nm and an emission wavelength was set at 380?nm till the elution of valsartan as well as internal standard and switched online to 320?nm for sacubitril. Analysis of analytes from rat plasma was carried out by protein precipitation using methanol and acetonitrile. Valsartan and sacubitril showed good linearity in the concentration range of 1–250?ng/ml and 1–200?ng/ml respectively, with good correlation coefficient (r²?≥?0.998). Further, the precision and accuracy of the proposed procedure were suitable as the percent relative standard deviation and percent relative error were well within the acceptable range. The average percent of recovery from the rat plasma was found to be 96.6% and 97.6% for valsartan and sacubitril respectively. The newly proposed method can be used for regular pharmacokinetic studies because of simplicity in sample preparation, short analysis time (<5?min) and good sensitivity.     

Simultaneous Quantitation of Minoxidil and Tretinoin in Magistral and Pharmaceutical Preparations by First Derivative Spectrophotometry

Abstract

A first derivative spectrophotometry method has been developed for the simultaneous quantitation of minoxidil and tretinoin. The method is based on measuring the first derivative signals (D₁) of minoxidil and tretinoin at 290 and 351 nm, respectively, without any interference from each other, or any other coexisting materials. Beer's law was valid over the concentration range 2–10 μg/ml of minoxidil and 0.25–1.25 μg/ml of tretinoin. The proposed method has been applied successfully to the determination of some magistral and pharmaceutical preparations. Relative standard deviations for the assay of both drugs were less than 0.95%.     

Simultaneous determination of rifampicin and isoniazid by continuous-flow chemiluminescence with artificial neural network calibration

In this paper a continuous-flow chemiluminescence (CL) system with artificial neural network calibration is proposed for simultaneous determination of rifampicin and isoniazid. This method is based on the different kinetic spectra of the analytes in their CL reaction with alkaline N-bromosuccinimide as oxidant. The CL intensity was measured and recorded every second from 1 to 300 s. The data obtained were processed chemometrically by use of an artificial neural network. The experimental calibration set was 20 sample solutions. The relative standard errors of prediction for both analytes were approximately 5%. The proposed method was successfully applied to the simultaneous determination of rifampicin and isoniazid in a combined pharmaceutical formulation.     

毛细管离子电泳法同时测定腌菜中硝酸根和亚硝酸根

以溴离子(Br-)为内标,建立了毛细管离子电泳同时测定腌菜中的硝酸根和亚硝酸根的方法。讨论了缓冲液pH、样品和缓冲液中氯化钠浓度、分离电压对分离的影响。结果表明:以含1mol LNaCl的40mmol LH3PO4 NaOH缓冲-、-得到基线分离。NO3-和NO2液(pH3.5)为背景电解质,4min内Br-、NO3-检出限分别为0.1g L和0.3g L,峰面积相对标准偏差分别为4.6%和NO25 8%。     

Simultaneous Determination of Trace Ofloxacin and Enoxacin by TLC-Fluorescence Spectrodensitometry

Abstract

A new TLC-fluorescence spectrodensitometry method is described for the simultaneous determination of trace ofloxacin and enoxacin, using a optimized mobile phase of chloroformmethanolethyl acetatetetrahydrofuranaqueous ammonia (6:4.6:1.5:0.8:1.5, V/V). The influence of the silica gel plates previously treated with various concentrations of sodium edetate solution in various pH's are studied. Their R, values are 0.54 and 0.29 respectively. The excitation, wavelength is 335nm. The linear ranges are 0~75ng. The relative standard deviations are <6.9%. The mean recovery of the two antibiotics in body fluid ranged from 95.4% to 105.2%.     

A rapid and sensitive UPLC‐MS/MS method for quantification of two caffeoylquinic acids and four main active components in rat plasma after an intravenous administration of Qingkailing injection and its application to a pharmacokinetic study

Qingkailing (QKL) injection, a modified modern Chinese medicine preparation, is widely used in the clinic for its significant antipyretic and anti‐inflammatory effects, but its serious adverse drug reactions have attracted more and more attention. Series of caffeoylquinic acids in QKL are widely suspected to be the allergens responsible for these adverse drug reactions. Therefore, pharmacokinetic studies of the caffeoylquinic acids are needed. In this paper, a simple, rapid and sensitive ultra‐performance liquid chromatography–tandem mass spectrometry method was developed for the simultaneous determination of chlorogenic acid, neochlorogenic acid, baicalin, geniposide, cholic acid and hyodeoxycholic acid in rat plasma. Chromatographic separation was achieved on a BEH C₁₈ column by a gradient elution at a flow rate of 0.40 mL/min in only 6.0 min. All analytes were monitored by multiple reaction monitoring mode with negative electrospray ionization. The calibration curves of these analytes were all linear (r > 0.9978) over wide concentration ranges. The intra‐ and inter‐ day precisions (relative standard deviations) were within 14.3% and accuracy (relative error) ranged from ?6.8 to 4.8%. The mean recoveries ranged from 74.5 to 105.6%. This validated method was successfully applied to the pharmacokinetic study of the six analytes in rats following an intravenous administration of QKL injection. Copyright © 2013 John Wiley & Sons, Ltd.     

New,simple, and validated UV-spectrophotometric method for the estimation of some beta blockers in bulk and formulations

A sensitive, extraction, derivatization, evaporation and complexation-free, direct spectrophotometric method is developed for the determination of some anthypertensive drugs such as acebutolol hydrochloride (ACH), atenolol (ATE), and propranolol hydrochloride (PRH) in bulk and pharmaceutical formulations. The optimum conditions for the analysis of aqua solutions of drugs are established. The method permits the determination of ACH, ATE, and PRH over a concentration range of 37.3–111.9, 53.3–213.1 and 14.8–51.8 μg/mL, respectively. Detection and quantification limits are calculated. The obtained results showed good recoveries of 99.60, 99.20 and 99.80% with relative standard deviations of 0.82, 0.79 and 1.70% for ACH, ATE, and PRH, respectively. The repeatability and reproducibility of the drugs for aqua media are determined. Precision and accuracy of the developed methods are used for the recovery studies. The proposed method is applicable for the assay of the three drugs under investigation in dosage forms and the results are in good agreement with those obtained by the literature method. The text was submitted by the author in English.     

Determination of Atenolol and Its Related Compounds by Ion Pair High Performance Liquid Chromatography

Abstract

A rapid, simple, accurate, and stability-indicating ion pair high performance liquid chromatography (IP HPLC) procedure is presented for the determination of atenolol in pharmaceutical tablets. The related compounds of atenolol were separated, making the determination specific for atenolol. An aliquot of the sample is dissolved in methanol containing N-butyryl-4-aminophenol as an internal standard and chromatographed on a supelcosil LC-8-DB (5μ) (25Omm × 4.6mm i.d.) column using 1.0 mM ammonium acetate and 2.0 mM octanesulfonic acid sodium salt in acetonitrile: water (25:75) solution adjusted to pH 3.5 with glacial acetic acid as the mobile phase. The detection was carried at 225 nm. The relative standard deviations are less than 1.0% for the two commercial products analyzed. The method was tested for linearity, recovery, and specificity.     

Application of principal component regression to the determination of Captopril by differential pulse polarography with no prior removal of dissolved oxygen

As shown in this paper, multivariate calibration in general and principal component regression (PCR) in particular allow the determination of Captopril by differential pulse polarography (DPP) in the presence of oxygen despite the overlap between their polarographic bands. Electrochemical parameters (pulse amplitude, pulse delay and drop time) are optimized from response surfaces using PCR to determine the relationship between the variables to be optimized and the relative square error of prediction (RSEP), which was adopted as the parameter to be minimized. The proposed method is quite fast and inexpensive as a result of the decreased analysis times and sparing use of the inert gas. It was applied to the determination of Captopril in synthetic samples and a commercially available pharmaceutical preparation, with relative errors and confidence intervals <2.5% and 2.0%, respectively. It should be noted that the sample can be analysed directly following dissolution in water without the need to remove the excipients.     

Simultaneous determination of ammonia and urea with an asymmetric merging zones/flow-injection configuration

A method is proposed for the simultaneous determination of urea and ammonia using a reagent-injection configuration that includes a dual injection valve (for insertion of Nessler's reagent and for accommodating the enzyme reactor). The resolution of the two peaks obtained on each injection allows the determination of both analytes in mixtures. The determination range is 1–5 μg ml^?1 for ammonia and 1–6 μg ml^?1 for urea, with relative standard deviations of 1.13% and 2.31% for ammonia (first and second peaks) and 1.86% for urea.